The American Gastroenterological Association requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the AGA policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Professor of Medicine
Division of Gastroenterology
Department of Medicine
University of California, San Francisco
UCSF Center for Colitis and Crohn's Disease
San Francisco, California
Chief of Pediatric Gastroenterology and Nutrition
Co-Director, Susan and Leonard Feinstein IBD Clinical Center
Icahn School of Medicine
Mount Sinai, New York
Manager, Editorial Operations
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Gastroenterological Association, Clinical Care Options, and the activity supporter do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the American Gastroenterological Association, Clinical Care Options, and the activity supporter. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This program is intended for gastroenterologists, primary care clinicians, OB/GYN healthcare providers, and other clinicians who care for women of childbearing age with IBD who hope to become pregnant and/or are considering planning a family.
American Gastroenterological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
American Gastroenterological Association designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
This program has been made available online.
Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 25, 2020, through March 24, 2021:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
Uma Mahadeven, MD, and Marla Dubinsky, MD: expert commentary on preconception strategies to ensure safe, effective IBD control before and during pregnancy
Gary R. Lichtenstein, MD, and Uma Mahadevan, MD: comparable efficacy, risks, and real-world data on biologic and small molecules therapies for moderate to severe UC
David Schwartz, MD, and Baldeep Pabla, MD: expert viewpoint on data from 2019 Crohn’s & Colitis Congress for mirikizumab, SHP647, ustekinumab in IBD
D. Brent Polk, MD, expert viewpoint on data from Crohn’s & Colitis Congress 2019 on proactive vs reactive drug monitoring approaches in IBD
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.